Lydia Roy
Centre Hospitalo-Universitaire Henri Mondor, Service d'Hematologie Clinique · Hôpital Henri Mondor - Créteil - France · CHU Henri Mondor, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lydia Roy as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:45 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03831776 · Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From DiagnosisSt. Olavs Hospital · completed · Chronic Myeloid Leukemia · principal investigator
- N/ANCT03208803 · Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in MyelofibrosisCentre Hospitalier Annecy Genevois · completed · Myelofibrosis; Anemia · study director
- N/ANCT03008642 · CO-Rebreathing in Comparison to Isotopic Red Cell Volume Determination in the Diagnosis of Primitive and Secondary PolycythemiaCentre Hospitalier Universitaire, Amiens · completed · Polycythemia · principal investigator
- Ph2/Ph3NCT02962388 · The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second LineFrench Innovative Leukemia Organisation · terminated · Essential Thrombocythemia · principal investigator
- Ph2NCT01872442 · Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic PhasePoitiers University Hospital · completed · Chronic Phase of Chronic Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:45 UTC. The ranking covers the 200 most relevant of 87 PubMed records, and a shared surname and initials can bring in a namesake. All 87 on PubMed
- 290 citationsRCR 7.5
- Antibiotic prophylaxis and recurrent urinary tract infection in children.N Engl J Med · 2009286 citationsRCR 10.9
- Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy.J Am Coll Cardiol · 2009226 citationsRCR 6.0
- Effectiveness of intensive rehabilitation on functional ability and quality of life after first total knee arthroplasty: A single-blind randomized controlled trial.Arch Phys Med Rehabil · 2004192 citationsRCR 8.2
- Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.Leukemia · 2008158 citationsRCR 3.5
- Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study.Circulation · 1996158 citationsRCR 4.3
- Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.J Clin Oncol · 2009147 citationsRCR 3.3
- Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty.Circulation · 1992126 citationsRCR 4.7
- Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants.N Engl J Med · 2004108 citationsRCR 3.8
- Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays.Clin Chem · 200093 citationsRCR 3.2